Value of proteomics technology in diagnosis of pancreatic cancer
10.3760/cma.j.issn.1673-4203.2010.03.017
- VernacularTitle:蛋白质组学技术在胰腺癌诊断中的价值
- Author:
Chunsheng ZHENG
;
Jiong CHEN
- Publication Type:Journal Article
- Keywords:
Proteomics;
Pancreatic tumor;
Diagnosis;
Biomarkers;
Recurrence;
Metastasis
- From:
International Journal of Surgery
2010;37(3):190-193
- CountryChina
- Language:Chinese
-
Abstract:
Pancreatic cancer is a highly malignant tumor of digestive tract which early diagnose is very difficult and has low rate of surgical resection of advanced pancreatic cancer. However, the rate of postoperative recurrence and metastas is high. Its prognosis is poor. To improve the prognosis of pancreatic cancer , it is necessary to improve its early diagnosis and effective prediction of postoperative recurrence and metastasis. In recent years, with the development of proteomics, the early diagnosis of pancreatic cancer and its early diagnosis of recurrence and metastasis was possible. Wsing proteomics technology for protein differences screening, isolation and identification is conductive to early detection of pancreatic proteome changes and establishment of the markers for early diagnosis, and recurrence and metastasis of pancreatic cancer.
